FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
14 letters match. Newest first.
-
DrugsVacation Inc.
FDA warned Vacation Inc. that its whipped-cream-style sunscreen mousses are unapproved drugs and that their food-like cans are misleading.
High risk -
DrugsKalani AB dba Kalani Sunwear
FDA warns Kalani AB that its Sun Mousse SPF 50 sunscreen is an unapproved, misbranded drug for US sale.
High risk -
DrugsK & Care Organics
FDA warns K & Care Organics over unapproved over-the-counter (OTC) foam sunscreen drugs sold in the U.S. without required authorization.
High risk -
DrugsFallien Cosmeceuticals Ltd. dba Fallene Ltd.
FDA warns Fallien over unapproved OTC sunscreen foam TiZO SHEERFOAM SPF 30 sold without required authorization.
Medium -
DrugsSupergoop!
FDA warned Supergoop! that its over-the-counter sunscreen body mousse is illegally labeled because foam dosage forms are not allowed under the sunscreen monograph.
Medium -
DrugsShenzhen Hengkaifeng Commerce and Trade Co., Ltd
Shenzhen Hengkaifeng's Sensitivity Toothpastes listing was inaccurate, making the drug misbranded, FDA says.
Low -
DrugsKabana Skin Care
FDA warned Kabana Skin Care that its "Kabana Body Wash +UV" is an unapproved, misbranded sunscreen drug sold without required FDA clearance.
Medium -
DrugsWaxhead Sun Defense Company
FDA warned Waxhead Sun Defense Company that its zinc body wash/shampoo is an unapproved, misbranded OTC sunscreen drug.
Medium -
DrugsCoLabs Intl. Corp
CoLabs Intl. Corp marketed KLĒNSKIN WASH ON SUNSCREEN, an OTC sunscreen wash, without an FDA-approved application or authorized dosage form.
Medium -
DrugsDr Sankunni’s Ayurvedic Research Foundation Private Ltd.
Dr Sankunni's Ayurvedic Research Foundation failed to correct drug listing and registration errors for its balms and hand sanitizer.
Low -
DrugsUS Specialty Formulations, LLC
US Specialty Formulations, a drug compounder registered as an outsourcing facility, made sterile compounded drugs under insanitary conditions.
High risk -
DrugsLydia Co. Ltd.
Lydia Co. Ltd. submitted mismatched drug listing data for eight products, leading FDA to remove them from its NDC Directory.
Low -
DrugsNew England Life Care, Inc. dba Advanced Compounding Solutions
FDA cites Advanced Compounding Solutions for insanitary sterile-drug production and CGMP failures after a 2022 inspection.
High risk -
DrugsMaitland Labs of Central Florida
FDA warns Maitland Labs of Central Florida over sterile compounded drugs with manufacturing quality failures, mislabeling, and unapproved new drug violations.
High risk